Cetera Investment Advisers Fibrogen Inc Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Fibrogen Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 12,055 shares of FGEN stock, worth $3,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,055
Previous 11,460
5.19%
Holding current value
$3,737
Previous $26,000
61.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
111Shares Held
58MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$4.23 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$2.77 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$1.82 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.04 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$746,9910.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $29.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...